Payment overview · 2025
General Payments
$75.49
4 reported records · 4 companies
Healthcare provider profile · identity verified
Robert Darrell Collins, D.O.
Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease · DOUGLAS, GA · NPI 1447250220
Verified facts
What the public records show
CMS Open Payments records show Robert Darrell Collins, D.O. received $75.49 in general payments during 2025 across 4 reported records.
SpringWorks Therapeutics, Inc. accounted for 26.4% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 4 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Jardiance, Ozempic.
Boehringer Ingelheim Pharmaceuticals, Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported JARDIANCE as an associated drug or biological on 123636 records involving 49438 distinct recipient NPIs. Public Medicare Part D data also shows 63 claims for Jardiance by this doctor in 2024.
Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Ozempic as an associated drug or biological on 261625 records involving 77793 distinct recipient NPIs. Public Medicare Part D data also shows 91 claims for Ozempic by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| SpringWorks Therapeutics, Inc. | Unresolved — no canonical attribution shown | $19.91 | 26.4% | 1 | 2025 |
| Novo Nordisk Inc | Unresolved — no canonical attribution shown | $19.12 | 25.3% | 1 | 2025 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | Unresolved — no canonical attribution shown | $18.85 | 25.0% | 1 | 2025 |
| Amgen Inc. | Unresolved — no canonical attribution shown | $17.61 | 23.3% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $56.64 | 3 |
| Education | $18.85 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| OGSIVEO Normalized: ogsiveo |
Drug | SpringWorks Therapeutics, Inc. | $19.91 | 1 | 2025 |
Source payment records
|
|||||
| Ozempic Normalized: ozempic |
Drug | Novo Nordisk Inc | $19.12 | 1 | 2025 |
Source payment records
|
|||||
| JARDIANCE Normalized: jardiance |
Drug | Boehringer Ingelheim Pharmaceuticals, Inc. | $18.85 | 1 | 2025 |
Source payment records
|
|||||
| REPATHA Normalized: repatha |
Biological | Amgen Inc. | $17.61 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| JARDIANCE jardiance |
2025 | Jardiance | 2024 | 63 | exact normalized | Medicare Part D |
| Ozempic ozempic |
2025 | Ozempic | 2024 | 91 | exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. Exact reporting entity; no affiliate inference |
2025 | JARDIANCE open payments reported associated product |
CMS Open Payments — General Payments 123636 supporting records · 49438 recipient NPIs · example record 1221811583 |
Jardiance · 2024 Exact normalized brand match · 1 Part D row |
63 | 16 |
| Novo Nordisk Inc Exact reporting entity; no affiliate inference |
2025 | Ozempic open payments reported associated product |
CMS Open Payments — General Payments 261625 supporting records · 77793 recipient NPIs · example record 1188130076 |
Ozempic · 2024 Exact normalized brand match · 1 Part D row |
91 | 16 |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Rosuvastatin Calcium | Rosuvastatin Calcium | 1559 | 398 |
| Atorvastatin Calcium | Atorvastatin Calcium | 1389 | 360 |
| Losartan Potassium | Losartan Potassium | 974 | 244 |
| Furosemide | Furosemide | 971 | 235 |
| Carvedilol | Carvedilol | 800 | 212 |
| Metoprolol Succinate | Metoprolol Succinate | 790 | 213 |
| Ezetimibe | Ezetimibe | 763 | 177 |
| Labetalol Hcl | Labetalol Hcl | 761 | 184 |
| Potassium Chloride | Potassium Chloride | 683 | 175 |
| Clopidogrel | Clopidogrel Bisulfate | 631 | 151 |
| Metoprolol Tartrate | Metoprolol Tartrate | 631 | 158 |
| Amlodipine Besylate | Amlodipine Besylate | 585 | 174 |
| Repatha Sureclick | Evolocumab | 544 | 94 |
| Lisinopril | Lisinopril | 536 | 130 |
| Entresto | Sacubitril/Valsartan | 485 | 111 |
| Eliquis | Apixaban | 475 | 94 |
| Chlorthalidone | Chlorthalidone | 462 | 127 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 459 | 115 |
| Simvastatin | Simvastatin | 451 | 119 |
| Xarelto | Rivaroxaban | 379 | 75 |
| Levothyroxine Sodium | Levothyroxine Sodium | 377 | 91 |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 358 | 86 |
| Pantoprazole Sodium | Pantoprazole Sodium | 321 | 69 |
| Nifedipine Er | Nifedipine | 307 | 73 |
| Fenofibrate | Fenofibrate | 265 | 59 |
| Hydrochlorothiazide | Hydrochlorothiazide | 258 | 71 |
| Pravastatin Sodium | Pravastatin Sodium | 254 | 68 |
| Hydralazine Hcl | Hydralazine Hcl | 238 | 76 |
| Famotidine | Famotidine | 230 | 64 |
| Prednisone | Prednisone | 209 | 155 |
| Nebivolol Hcl | Nebivolol Hcl | 206 | 46 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 204 | 87 |
| Metformin Hcl | Metformin Hcl | 194 | 50 |
| Warfarin Sodium | Warfarin Sodium | 178 | 26 |
| Omeprazole | Omeprazole | 177 | 50 |
| Spironolactone | Spironolactone | 176 | 42 |
| Nitroglycerin | Nitroglycerin | 175 | 106 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 171 | 43 |
| Allopurinol | Allopurinol | 164 | 34 |
| Gabapentin | Gabapentin | 157 | 43 |
| Amiodarone Hcl | Amiodarone Hcl | 152 | 32 |
| Sotalol | Sotalol Hcl | 130 | 25 |
| Propafenone Hcl | Propafenone Hcl | 124 | 34 |
| Doxycycline Hyclate | Doxycycline Hyclate | 123 | 107 |
| Midodrine Hcl | Midodrine Hcl | 121 | 36 |
| Metolazone | Metolazone | 115 | 30 |
| Cefuroxime | Cefuroxime Axetil | 114 | 99 |
| Montelukast Sodium | Montelukast Sodium | 112 | 23 |
| Flecainide Acetate | Flecainide Acetate | 106 | 22 |
| Vascepa | Icosapent Ethyl | 105 | 24 |
| Valsartan | Valsartan | 101 | 25 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 99 | 76 |
| Bumetanide | Bumetanide | 95 | 17 |
| Meloxicam | Meloxicam | 95 | 18 |
| Mounjaro | Tirzepatide | 93 | 15 |
| Ozempic | Semaglutide | 91 | 16 |
| Diclofenac Sodium | Diclofenac Sodium | 85 | 38 |
| Sertraline Hcl | Sertraline Hcl | 85 | 19 |
| Glyburide | Glyburide | 82 | 16 |
| Clonidine Hcl | Clonidine Hcl | 80 | 26 |
| Farxiga | Dapagliflozin Propanediol | 80 | 21 |
| Gemfibrozil | Gemfibrozil | 80 | 13 |
| Escitalopram Oxalate | Escitalopram Oxalate | 79 | 17 |
| Tamsulosin Hcl | Tamsulosin Hcl | 75 | 23 |
| Quetiapine Fumarate | Quetiapine Fumarate | 73 | 12 |
| Tramadol Hcl | Tramadol Hcl | 73 | 36 |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 71 | 17 |
| Citalopram Hbr | Citalopram Hydrobromide | 71 | 16 |
| Pioglitazone Hcl | Pioglitazone Hcl | 71 | 11 |
| Buspirone Hcl | Buspirone Hcl | 68 | 21 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 68 | 60 |
| Praluent Pen | Alirocumab | 68 | 18 |
| Azithromycin | Azithromycin | 67 | 60 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 66 | 19 |
| Fenofibrate | Fenofibrate Nanocrystallized | 64 | 22 |
| Ranolazine Er | Ranolazine | 64 | 16 |
| Glimepiride | Glimepiride | 63 | 17 |
| Jardiance | Empagliflozin | 63 | 16 |
| Brilinta | Ticagrelor | 61 | 15 |
| Trazodone Hcl | Trazodone Hcl | 61 | 15 |
| Glipizide | Glipizide | 59 | 13 |
| Amitriptyline Hcl | Amitriptyline Hcl | 57 | 15 |
| Ropinirole Hcl | Ropinirole Hcl | 56 | 13 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 53 | 11 |
| Ondansetron Odt | Ondansetron | 53 | 34 |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 51 | 14 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 49 | 13 |
| Digoxin | Digoxin | 46 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 46 | 18 |
| Klor-Con M20 | Potassium Chloride | 46 | 21 |
| Tizanidine Hcl | Tizanidine Hcl | 46 | 12 |
| Fluticasone Propionate | Fluticasone Propionate | 45 | 14 |
| Metformin Hcl Er | Metformin Hcl | 45 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 45 | 13 |
| Ventolin Hfa | Albuterol Sulfate | 45 | suppressed |
| Duloxetine Hcl | Duloxetine Hcl | 44 | suppressed |
| Clonidine | Clonidine | 43 | suppressed |
| Synthroid | Levothyroxine Sodium | 40 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 39 | 14 |
| Sucralfate | Sucralfate | 38 | 14 |
| Testosterone Cypionate | Testosterone Cypionate | 37 | suppressed |
| Nitroglycerin Patch | Nitroglycerin | 36 | suppressed |
| Livalo | Pitavastatin Calcium | 35 | 12 |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 34 | suppressed |
| Celecoxib | Celecoxib | 33 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 33 | suppressed |
| Linzess | Linaclotide | 33 | 12 |
| Ondansetron Hcl | Ondansetron Hcl | 33 | 11 |
| Amoxicillin | Amoxicillin | 32 | 26 |
| Bupropion Xl | Bupropion Hcl | 32 | suppressed |
| Isosorbide Mononitrate | Isosorbide Mononitrate | 31 | suppressed |
| Donepezil Hcl | Donepezil Hcl | 30 | 11 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 30 | 11 |
| Ramipril | Ramipril | 30 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 29 | suppressed |
| Lovastatin | Lovastatin | 29 | suppressed |
| Finasteride | Finasteride | 28 | suppressed |
| Repatha Syringe | Evolocumab | 28 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 26 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 25 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 25 | 11 |
| Divalproex Sodium | Divalproex Sodium | 25 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 25 | suppressed |
| Levetiracetam | Levetiracetam | 25 | suppressed |
| Pitavastatin Calcium | Pitavastatin Calcium | 25 | suppressed |
| Varenicline Tartrate | Varenicline Tartrate | 25 | 15 |
| Alendronate Sodium | Alendronate Sodium | 24 | suppressed |
| Atenolol | Atenolol | 24 | suppressed |
| Levofloxacin | Levofloxacin | 24 | 19 |
| Meclizine Hcl | Meclizine Hcl | 24 | 13 |
| Oseltamivir Phosphate | Oseltamivir Phosphate | 24 | 23 |
| Oxycodone Hcl | Oxycodone Hcl | 24 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 23 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 23 | suppressed |
| Nystatin | Nystatin | 23 | 14 |
| Colesevelam Hcl | Colesevelam Hcl | 22 | suppressed |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 21 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 21 | suppressed |
| Torsemide | Torsemide | 21 | suppressed |
| Fluconazole | Fluconazole | 20 | 16 |
| Glipizide Er | Glipizide | 20 | suppressed |
| Methylprednisolone | Methylprednisolone | 20 | 20 |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 19 | suppressed |
| Prasugrel Hcl | Prasugrel Hcl | 19 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 18 | suppressed |
| Ibuprofen | Ibuprofen | 17 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 17 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 17 | 12 |
| Benztropine Mesylate | Benztropine Mesylate | 16 | suppressed |
| Clindamycin Hcl | Clindamycin Hcl | 16 | 14 |
| Jantoven | Warfarin Sodium | 16 | suppressed |
| Megestrol Acetate | Megestrol Acetate | 16 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 16 | 16 |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 16 | suppressed |
| Baclofen | Baclofen | 15 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 15 | suppressed |
| Ceftriaxone | Ceftriaxone Sodium | 15 | 12 |
| Januvia | Sitagliptin Phosphate | 15 | suppressed |
| Lidocaine Hcl | Lidocaine Hcl/Pf | 15 | 12 |
| Minoxidil | Minoxidil | 15 | suppressed |
| Cyproheptadine Hcl | Cyproheptadine Hcl | 14 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 14 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 14 | suppressed |
| Pregabalin | Pregabalin | 14 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 14 | suppressed |
| Advair Hfa | Fluticasone Propion/Salmeterol | 13 | suppressed |
| Corlanor | Ivabradine Hcl | 13 | suppressed |
| Eplerenone | Eplerenone | 13 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 13 | suppressed |
| Sildenafil Citrate | Sildenafil Citrate | 13 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 13 | suppressed |
| Verapamil Hcl | Verapamil Hcl | 13 | suppressed |
| Bisoprolol-Hydrochlorothiazide | Bisoprolol/Hydrochlorothiazide | 12 | suppressed |
| Diclofenac Potassium | Diclofenac Potassium | 12 | suppressed |
| Eszopiclone | Eszopiclone | 12 | suppressed |
| Fenofibrate | Fenofibrate,micronized | 12 | suppressed |
| Glycopyrrolate | Glycopyrrolate | 12 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 12 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 12 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 12 | suppressed |
| Acebutolol Hcl | Acebutolol Hcl | 11 | suppressed |
| Cilostazol | Cilostazol | 11 | suppressed |
| Colchicine | Colchicine | 11 | suppressed |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 11 | suppressed |
| Icosapent Ethyl | Icosapent Ethyl | 11 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 11 | suppressed |
| Mexiletine Hcl | Mexiletine Hcl | 11 | suppressed |
| Mirtazapine | Mirtazapine | 11 | suppressed |
| Potassium Citrate Er | Potassium Citrate | 11 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 11 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 11 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $75.49 · 4 records | SpringWorks Therapeutics, Inc. | JARDIANCE, OGSIVEO, Ozempic, REPATHA | 2 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Jardiance play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with Boehringer Ingelheim Pharmaceuticals, Inc.?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error